Xeris Biopharma Holdings Inc (XERS)
Net Debt
$167.70M
Quarterly · Period ending: · USD
XERS Net Debt
Latest reported$167.70Mperiod ending
Latest reported$167.70Mperiod ending
XERS Quarterly Net Debt ($32.27M → $167.70M)
Quarterly net debt
High-resolution chart · PNG
XERS net debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Debt (USD) |
|---|---|
| 167,695,000 | |
| -74,421,000 | |
| -73,279,000 | |
| -53,413,000 | |
| 197,938,000 | |
| 210,311,000 | |
| 199,826,000 | |
| 211,733,000 | |
| 212,200,000 | |
| 206,005,000 | |
| 161,742,000 | |
| 181,800,000 | |
| 178,818,000 | |
| 147,433,000 | |
| 76,091,000 | |
| 54,398,000 | |
| 42,728,000 | |
| 34,209,000 | |
| 20,796,000 | |
| 28,221,000 | |
| 23,879,000 | |
| 20,668,000 | |
| 49,423,000 | |
| 81,505,000 | |
| 7,011,000 | |
| 19,241,000 | |
| 38,786,000 | |
| 1,964,000 | |
| -34,266,000 | |
| -29,843,000 | |
| -13,826,000 | |
| -44,103,000 | |
| -116,361,000 | |
| -40,059,000 | |
| -42,045,000 | |
| 32,269,000 |